Related Experiment Video
Updated: May 22, 2026
09:38
Scaling of Engineered Vascular Grafts Using 3D Printed Guides and the Ring Stacking Method
Published on: March 27, 2017
Bioengineered vascular grafts: can we make them off-the-shelf?
Shannon L M Dahl1, Juliana L Blum, Laura E Niklason
1Humacyte, Inc., Research Triangle Park, NC 27709, USA. dahl@humacyte.com
Trends in Cardiovascular Medicine
|May 26, 2012
Summary
Advancements in vascular grafting materials, from autologous to bioengineered conduits, aim to treat severe vascular disease. Bioengineered grafts show promise but require immediate "off-the-shelf" availability for clinical impact.
Area of Science:
- Biomedical Engineering
- Vascular Surgery
- Regenerative Medicine
Background:
- Vascular disease treatment has evolved over a century, seeking alternatives to autologous bypass grafts.
- Existing alternatives like synthetic, animal-derived, and cryopreserved grafts have limitations in availability and function.
- Severe vascular disease necessitates bypass grafting, especially for patients lacking suitable autologous conduits.
Purpose of the Study:
- To review the progression of vascular grafting materials.
- To highlight the limitations of current non-autologous grafting options.
- To discuss the potential and requirements of bioengineered vascular grafts.
Main Methods:
- Literature review of historical and current vascular grafting technologies.
- Analysis of the advantages and disadvantages of various graft materials.
- Exploration of the developmental status and future needs of bioengineered grafts.
Main Results:
- Vascular grafting has progressed through synthetic, animal-derived, and cryopreserved materials, each with drawbacks.
- Bioengineered vascular grafts represent a promising investigational technology.
- Current limitations for bioengineered grafts include the need for immediate, "off-the-shelf" availability.
Conclusions:
- Bioengineered vascular grafts hold revolutionary potential for treating severe vascular disease.
- Overcoming current limitations, particularly in accessibility, is crucial for clinical adoption.
- Further development is needed to make bioengineered grafts a viable, readily available option.
